Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Expert Opin Drug Discov. 2016 Dec 9;12(2):213–224. doi: 10.1080/17460441.2017.1268121

Table 1.

Representative CE enzyme assay screens and demonstrations

Target Assay Type Compounds Assayed Z-score Reference
tyrosine phosphatase commercial microchip platform 12,648 0.61 [8]
Sirt5 segmented flow coupled to MCE 1,280 0.8 [16]
glycerol kinase EMMA 1 N.D. [88]
aminopeptidase N EMMA 30* N.D. [86]
neuraminidase EMMA 24* N.D. [83]
β-N-acetylhexosaminidase TDLFP 1 N.D. [92]
four human kinases: GSK3β, DYRK1A, CDK5/p25, CDK1/cylcin B TDLFP 13 N.D. [93]
adenosine deaminase and xanthine oxidase CE-based IMERs 20* 0.82, 0.74 [101]
L-glutamic dehydrogenase CE-based IMERs 26* 0.95 [100]
glucose-6-phosphate dehydrogenase CE-based IMERs 6 N.D. [97]
alkaline phosphatases CE-based IMERs 3 N.D. [96]
acetylcholinesterase CE-based IMERs 46* 0.9 [95]
angiotensin-converting enzyme CE-based IMERs 34* N.D. [94]

Not determined (N.D.); electrophoretically mediated microanalysis (EMMA); transverse diffusion of laminar flow profiles (TDLFP); capillary electrophoresis-based immobilized enzyme reactors (CE-based IMERs)

*

includes crude product, natural extract, or chinese traditional herb